Priority Review Voucher

The latest news about Priority Review Voucher: headlines, AI summaries and the full story from every source.

• BioNTech Acquires Rare Pediatric Disease Priority Review Voucher from Scholar Rock for $205 Million Seeking Alpha · November 10, 2026, 13:08 UTC
• Denali Therapeutics Reports Q3 2026 Earnings Driven by AVLAYAH Commercial Launch Motley Fool · November 4, 2026, 15:09 UTC
• Ultragenyx to Sell FDA Priority Review Voucher for $210 Million Seeking Alpha · October 7, 2026, 14:09 UTC